We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UNH vs. MOH: Which Managed Care Stock Looks More Attractive?
Read MoreHide Full Article
Key Takeaways
MOH sees 2026 as the Medicaid profit trough and is shifting Medicare toward dual-eligible plans.
MOH is targeting $64 billion in premium revenues by 2029 through Medicaid, Medicare duals and acquisitions.
UNH's Q2 2026 medical care ratio improved to 86.7%, while operating income rose to $3.9B.
Healthcare insurers are navigating a shifting cost environment while balancing membership trends, pricing discipline and the need to improve care delivery efficiency. These factors are placing greater emphasis on how managed care companies manage medical costs and allocate resources across government-sponsored and commercial businesses.
UnitedHealth Group Incorporated (UNH - Free Report) and Molina Healthcare, Inc. (MOH - Free Report) both operate in managed care, but their business models have different levels of diversification. UNH combines UnitedHealthcare with its broad Optum platform spanning care delivery, technology, analytics and pharmacy services, while MOH remains more concentrated in government-sponsored healthcare, particularly Medicaid, Medicare and Marketplace programs.
Let’s dive deep and closely compare the fundamentals of the two stocks to determine which one is a better investment now.
The Case for UNH
UnitedHealth’s earnings recovery is increasingly being driven by better economics at UnitedHealthcare rather than pure membership expansion. The second-quarter medical care ratio improved to 86.7% from 89.4% a year earlier, aided by pricing discipline, benefit redesign, business mix and medical cost initiatives. UnitedHealthcare generated revenues of $86 billion in the second quarter of 2026, while operating income climbed to $3.9 billion from $2.1 billion a year ago.
Technology is another important efficiency lever for UnitedHealthcare. The business is using digital tools and automation to simplify claims processing, prior authorization, benefit administration and member navigation, helping reduce administrative friction and improve service delivery. Its operating margin improved to 4.6% in the second quarter of 2026 from 2.4% a year ago, despite membership pressure in Medicare Advantage and Medicaid.
Optum Health remains a key long-term growth pillar as UnitedHealth expands value-based care and shifts more treatment toward lower-cost settings. Its integrated care model combines physician services, ambulatory care and home-based programs, giving the company opportunities to improve outcomes while reducing unnecessary hospital utilization. Optum is also extending home-based care in rural markets, where it already reaches nearly 90% of U.S. counties and conducts about 2.5 million rural patient home visits annually.
Optum Rx and Optum Insight further diversify UnitedHealth beyond traditional health insurance. The company is expanding transparent pharmacy arrangements, healthcare analytics and technology solutions for payers and providers. Together, these businesses give UNH several avenues for growth while reducing its dependence on any single managed-care market. In the second quarter of 2026, Optum’s adjusted operating margin improved to 6.1% from 4.6% a year ago. UNH beat earnings in each of the past four quarters with an average surprise of 12.1%.
UnitedHealth Group Incorporated Price, Consensus and EPS Surprise
UNH also maintains a relatively solid financial position. It ended the June quarter with $31.5 billion in cash and short-term investments, sufficient to cover its short-term borrowings and current maturities of long-term debt, which stand at $3.8 billion. Its total debt-to-capital of 41.2% is below MOH’s 48.7% and the industry’s 41.5%. This balance-sheet flexibility supports continued investment in technology, care delivery and other strategic initiatives.
The Case for MOH
Medicaid remains the foundation of Molina Healthcare’s business and a key source of its expected earnings recovery. Medicaid generated $8 billion of premium revenues in the second quarter of 2026. Medical cost trends remained stable, and MOH expects Medicaid margins to improve as future rate increases better reflect underlying cost trends. The company views 2026 as the trough year for Medicaid profitability.
Medicare is also becoming a key growth and earnings contributor, particularly through dual-eligible products. The segment’s second-quarter MCR was 90.7%, driven by lower medical cost trends in several categories and pricing implemented for 2026. The company plans to exit its traditional Medicare Advantage Part D (MAPD) business in 2027 and direct resources toward integrated plans serving members eligible for both Medicare and Medicaid. This initiative should create a more focused Medicare portfolio while supporting deeper penetration in existing markets.
Contract wins and renewals remain central to MOH’s growth strategy. The company continues to defend existing Medicaid franchises while pursuing new state contracts and opportunities in integrated dual-eligible programs. This approach provides a path to expand its membership and premium base. Molina Healthcare is also using portfolio discipline and operating leverage to support longer-term growth. It is reducing Marketplace exposure while allocating resources toward Medicaid, Medicare duals and selective acquisitions. The company continues to target $64 billion of premium revenues by 2029.
Molina Healthcare is also investing in technology and AI to improve operating efficiency and medical-cost management. The company has migrated to a cloud-based architecture and is using analytics to generate insights for members and state partners. Its AI initiatives are aimed at automating administrative processes and improving managed-care operations. Molina Healthcare also exited the second quarter of 2026 with cash and cash equivalents of $5 billion, which increased from the 2025-end level of $4.2 billion, providing flexibility for acquisitions and other strategic investments.
However, it missed the earnings estimates in two of the past four quarters and beat twice.
Molina Healthcare, Inc Price, Consensus and EPS Surprise
The Zacks Consensus Estimate for UNH’s 2026 EPS is pegged at $19.85, indicating 21.4% year-over-year growth. The same for 2027 earnings suggests a 13.6% increase to $22.55 per share. Meanwhile, the consensus estimate for 2026 revenues is pegged at $446.8 billion.
The consensus mark for Molina Healthcare’s 2026 EPS is pegged at $5.29, a 52% decrease from a year ago. However, the same for 2027 predicts an 84.6% rise to $9.76. Meanwhile, the consensus estimate for 2026 revenues is pegged at $44.5 billion. The sharp projected earnings rebound suggests stronger recovery potential for MOH, making its long-term growth outlook appear more compelling compared with UNH.
Valuation: UNH vs. MOH
Coming to the valuation story, it seems that investors are willing to pay a premium for Molina Healthcare compared to UnitedHealth. This is reflected in MOH’s forward 12-month price/earnings (P/E) of 22.37X compared with UNH’s 17.10X and the industry average of 15.21X.
Image Source: Zacks Investment Research
Price Performance Comparison
In the past three months, shares of UnitedHealth have fallen 8.1% compared with Molina Healthcare’s 5.1% decline and the industry’s 4.6% dip. During this time, the S&P 500 has risen 5.2%.
3-Month Price Performance – UNH, MOH, Industry & S&P 500
Image Source: Zacks Investment Research
Conclusion
UNH offers greater diversification through UnitedHealthcare and Optum, supported by improving profitability and a stronger balance sheet. However, membership pressure and the ongoing recovery in its core insurance business remain key considerations.
Meanwhile, MOH offers a more focused recovery story, supported by stabilizing Medicaid economics, growth in Medicare duals, new contract wins and a leaner Marketplace portfolio. Despite its higher valuation, its stronger projected earnings rebound makes MOH the more attractive stock at present.
View the Zacks #1 Rank List
Image: Bigstock
UNH vs. MOH: Which Managed Care Stock Looks More Attractive?
Key Takeaways
Healthcare insurers are navigating a shifting cost environment while balancing membership trends, pricing discipline and the need to improve care delivery efficiency. These factors are placing greater emphasis on how managed care companies manage medical costs and allocate resources across government-sponsored and commercial businesses.
UnitedHealth Group Incorporated (UNH - Free Report) and Molina Healthcare, Inc. (MOH - Free Report) both operate in managed care, but their business models have different levels of diversification. UNH combines UnitedHealthcare with its broad Optum platform spanning care delivery, technology, analytics and pharmacy services, while MOH remains more concentrated in government-sponsored healthcare, particularly Medicaid, Medicare and Marketplace programs.
Let’s dive deep and closely compare the fundamentals of the two stocks to determine which one is a better investment now.
The Case for UNH
UnitedHealth’s earnings recovery is increasingly being driven by better economics at UnitedHealthcare rather than pure membership expansion. The second-quarter medical care ratio improved to 86.7% from 89.4% a year earlier, aided by pricing discipline, benefit redesign, business mix and medical cost initiatives. UnitedHealthcare generated revenues of $86 billion in the second quarter of 2026, while operating income climbed to $3.9 billion from $2.1 billion a year ago.
Technology is another important efficiency lever for UnitedHealthcare. The business is using digital tools and automation to simplify claims processing, prior authorization, benefit administration and member navigation, helping reduce administrative friction and improve service delivery. Its operating margin improved to 4.6% in the second quarter of 2026 from 2.4% a year ago, despite membership pressure in Medicare Advantage and Medicaid.
Optum Health remains a key long-term growth pillar as UnitedHealth expands value-based care and shifts more treatment toward lower-cost settings. Its integrated care model combines physician services, ambulatory care and home-based programs, giving the company opportunities to improve outcomes while reducing unnecessary hospital utilization. Optum is also extending home-based care in rural markets, where it already reaches nearly 90% of U.S. counties and conducts about 2.5 million rural patient home visits annually.
Optum Rx and Optum Insight further diversify UnitedHealth beyond traditional health insurance. The company is expanding transparent pharmacy arrangements, healthcare analytics and technology solutions for payers and providers. Together, these businesses give UNH several avenues for growth while reducing its dependence on any single managed-care market. In the second quarter of 2026, Optum’s adjusted operating margin improved to 6.1% from 4.6% a year ago. UNH beat earnings in each of the past four quarters with an average surprise of 12.1%.
UnitedHealth Group Incorporated Price, Consensus and EPS Surprise
UnitedHealth Group Incorporated price-consensus-eps-surprise-chart | UnitedHealth Group Incorporated Quote
UNH also maintains a relatively solid financial position. It ended the June quarter with $31.5 billion in cash and short-term investments, sufficient to cover its short-term borrowings and current maturities of long-term debt, which stand at $3.8 billion. Its total debt-to-capital of 41.2% is below MOH’s 48.7% and the industry’s 41.5%. This balance-sheet flexibility supports continued investment in technology, care delivery and other strategic initiatives.
The Case for MOH
Medicaid remains the foundation of Molina Healthcare’s business and a key source of its expected earnings recovery. Medicaid generated $8 billion of premium revenues in the second quarter of 2026. Medical cost trends remained stable, and MOH expects Medicaid margins to improve as future rate increases better reflect underlying cost trends. The company views 2026 as the trough year for Medicaid profitability.
Medicare is also becoming a key growth and earnings contributor, particularly through dual-eligible products. The segment’s second-quarter MCR was 90.7%, driven by lower medical cost trends in several categories and pricing implemented for 2026. The company plans to exit its traditional Medicare Advantage Part D (MAPD) business in 2027 and direct resources toward integrated plans serving members eligible for both Medicare and Medicaid. This initiative should create a more focused Medicare portfolio while supporting deeper penetration in existing markets.
Contract wins and renewals remain central to MOH’s growth strategy. The company continues to defend existing Medicaid franchises while pursuing new state contracts and opportunities in integrated dual-eligible programs. This approach provides a path to expand its membership and premium base. Molina Healthcare is also using portfolio discipline and operating leverage to support longer-term growth. It is reducing Marketplace exposure while allocating resources toward Medicaid, Medicare duals and selective acquisitions. The company continues to target $64 billion of premium revenues by 2029.
Molina Healthcare is also investing in technology and AI to improve operating efficiency and medical-cost management. The company has migrated to a cloud-based architecture and is using analytics to generate insights for members and state partners. Its AI initiatives are aimed at automating administrative processes and improving managed-care operations. Molina Healthcare also exited the second quarter of 2026 with cash and cash equivalents of $5 billion, which increased from the 2025-end level of $4.2 billion, providing flexibility for acquisitions and other strategic investments.
However, it missed the earnings estimates in two of the past four quarters and beat twice.
Molina Healthcare, Inc Price, Consensus and EPS Surprise
Molina Healthcare, Inc price-consensus-eps-surprise-chart | Molina Healthcare, Inc Quote
How Do Estimates Compare for UNH & MOH?
The Zacks Consensus Estimate for UNH’s 2026 EPS is pegged at $19.85, indicating 21.4% year-over-year growth. The same for 2027 earnings suggests a 13.6% increase to $22.55 per share. Meanwhile, the consensus estimate for 2026 revenues is pegged at $446.8 billion.
The consensus mark for Molina Healthcare’s 2026 EPS is pegged at $5.29, a 52% decrease from a year ago. However, the same for 2027 predicts an 84.6% rise to $9.76. Meanwhile, the consensus estimate for 2026 revenues is pegged at $44.5 billion. The sharp projected earnings rebound suggests stronger recovery potential for MOH, making its long-term growth outlook appear more compelling compared with UNH.
Valuation: UNH vs. MOH
Coming to the valuation story, it seems that investors are willing to pay a premium for Molina Healthcare compared to UnitedHealth. This is reflected in MOH’s forward 12-month price/earnings (P/E) of 22.37X compared with UNH’s 17.10X and the industry average of 15.21X.
Image Source: Zacks Investment Research
Price Performance Comparison
In the past three months, shares of UnitedHealth have fallen 8.1% compared with Molina Healthcare’s 5.1% decline and the industry’s 4.6% dip. During this time, the S&P 500 has risen 5.2%.
3-Month Price Performance – UNH, MOH, Industry & S&P 500
Image Source: Zacks Investment Research
Conclusion
UNH offers greater diversification through UnitedHealthcare and Optum, supported by improving profitability and a stronger balance sheet. However, membership pressure and the ongoing recovery in its core insurance business remain key considerations.
Meanwhile, MOH offers a more focused recovery story, supported by stabilizing Medicaid economics, growth in Medicare duals, new contract wins and a leaner Marketplace portfolio. Despite its higher valuation, its stronger projected earnings rebound makes MOH the more attractive stock at present.
Molina Healthcare currently flaunts a Zacks Rank #1 (Strong Buy), while UnitedHealth carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.